ECST-2 is an international randomised trial investigating the optimal treatment of patients with symptomatic or asymptomatic moderate or severe carotid stenosis at low or intermediate risk of future stroke. The trial compares the risks and benefits of treatment by modern optimized medical management alone versus the addition of immediate carotid surgery (or stenting) to optimised medical management.
The trial is currently recruiting new centres and participants.
ECST-2 has been co-adopted onto the NIHR Clinical Research Network Portfolio in the specialty areas of both Stroke and Surgery.
more information about the trial, please read the protocol
you have any questions about the trial, please contact